SZSE:002750 (China)
Â
Class A
Â¥
2.90
(-3.01%)
May 23
Current and historical daily PE Ratio for Kunming Longjin Pharmaceutical Co Ltd (
SZSE:002750
) from 2015 to May 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Kunming Longjin Pharmaceutical stock (SZSE:002750) PE ratio as of May 23 2024 is 0.
More Details
Kunming Longjin Pharmaceutical Co Ltd (SZSE:002750) PE Ratio (TTM) Chart
Kunming Longjin Pharmaceutical Co Ltd (SZSE:002750) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1193
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Kunming Longjin Pharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-24 | At Loss | 2024-03-18 | At Loss |
| 2024-05-23 | At Loss | 2024-03-15 | At Loss |
| 2024-05-22 | At Loss | 2024-03-14 | At Loss |
| 2024-05-21 | At Loss | 2024-03-13 | At Loss |
| 2024-05-20 | At Loss | 2024-03-12 | At Loss |
| 2024-05-17 | At Loss | 2024-03-11 | At Loss |
| 2024-05-16 | At Loss | 2024-03-08 | At Loss |
| 2024-05-15 | At Loss | 2024-03-07 | At Loss |
| 2024-05-14 | At Loss | 2024-03-06 | At Loss |
| 2024-05-13 | At Loss | 2024-03-05 | At Loss |
| 2024-05-10 | At Loss | 2024-03-04 | At Loss |
| 2024-05-09 | At Loss | 2024-03-01 | At Loss |
| 2024-05-08 | At Loss | 2024-02-29 | At Loss |
| 2024-05-07 | At Loss | 2024-02-28 | At Loss |
| 2024-05-06 | At Loss | 2024-02-27 | At Loss |
| 2024-04-30 | At Loss | 2024-02-26 | At Loss |
| 2024-04-29 | At Loss | 2024-02-23 | At Loss |
| 2024-04-26 | At Loss | 2024-02-22 | At Loss |
| 2024-04-25 | At Loss | 2024-02-21 | At Loss |
| 2024-04-24 | At Loss | 2024-02-20 | At Loss |
| 2024-04-23 | At Loss | 2024-02-19 | At Loss |
| 2024-04-22 | At Loss | 2024-02-16 | At Loss |
| 2024-04-19 | At Loss | 2024-02-09 | At Loss |
| 2024-04-18 | At Loss | 2024-02-08 | At Loss |
| 2024-04-17 | At Loss | 2024-02-07 | At Loss |
| 2024-04-16 | At Loss | 2024-02-06 | At Loss |
| 2024-04-15 | At Loss | 2024-02-05 | At Loss |
| 2024-04-12 | At Loss | 2024-02-02 | At Loss |
| 2024-04-11 | At Loss | 2024-02-01 | At Loss |
| 2024-04-10 | At Loss | 2024-01-31 | At Loss |
| 2024-04-09 | At Loss | 2024-01-30 | At Loss |
| 2024-04-08 | At Loss | 2024-01-29 | At Loss |
| 2024-04-05 | At Loss | 2024-01-26 | At Loss |
| 2024-04-03 | At Loss | 2024-01-25 | At Loss |
| 2024-04-02 | At Loss | 2024-01-24 | At Loss |
| 2024-04-01 | At Loss | 2024-01-23 | At Loss |
| 2024-03-29 | At Loss | 2024-01-22 | At Loss |
| 2024-03-28 | At Loss | 2024-01-19 | At Loss |
| 2024-03-27 | At Loss | 2024-01-18 | At Loss |
| 2024-03-26 | At Loss | 2024-01-17 | At Loss |
| 2024-03-25 | At Loss | 2024-01-16 | At Loss |
| 2024-03-22 | At Loss | 2024-01-15 | At Loss |
| 2024-03-21 | At Loss | 2024-01-12 | At Loss |
| 2024-03-20 | At Loss | 2024-01-11 | At Loss |
| 2024-03-19 | At Loss | 2024-01-10 | At Loss |
Kunming Longjin Pharmaceutical Co Ltd (SZSE:002750) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Kunming Longjin Pharmaceutical Co Ltd
ISIN : CNE1000021X8
Share Class Description:
SZSE:002750: Class ACompare
Compare
Traded in other countries / regions
002750.China IPO Date
2015-03-24Description
Kunming Longjin Pharmaceutical Co Ltd is a pharmaceutical company. It develops, produces and sells natural botanical and chemical freeze-dried powder injections. It also has freeze-dried powder injection line. Its products include Chinese medicine, biochemical medicine, chemical medicine, cardio-cerebral vascular medicine, digestive system medicine, immune system medicine, vitamins, minerals, enteral and parenteral nutrition.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers